Optometrists best placed to screen population

Article

Although almost a third of patients referred by optometrists do not have glaucoma, optometrists are still best placed to screen the UK population for glaucoma, according to Dr Aye and colleagues from Northampton General Hospital, UK.

Although almost a third of patients referred by optometrists do not have glaucoma, optometrists are still best placed to screen the UK population for glaucoma, according to Dr Aye and colleagues from Northampton General Hospital, UK.

A study was conducted to review the glaucoma data provided by optometrists on referral forms. A total of 78 referrals were received over a five-month period. The most common reasons for referral were elevated IOP (59%), optic disc abnormalities (45%), visual field defects (14%) and other abnormalities (12%).

A total of 68% of forms were incomplete, missing vital data. Of the IOP measurements, 38% were within 2 mmHg of IOP obtained with Goldmann tonometry and 34% of pneumatonometry readings differed by more than 5 mmHg with that obtained by applanation tonometry. Twenty-seven percent of patients were found not to have glaucoma and were discharged, while 26% of patients were started on treatment.

According to the investigators, despite varying IOP measurements, optometrists are still best placed to screen the UK population for glaucoma.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.